Search

Your search keyword '"Bouvry, Diane"' showing total 150 results

Search Constraints

Start Over You searched for: Author "Bouvry, Diane" Remove constraint Author: "Bouvry, Diane"
150 results on '"Bouvry, Diane"'

Search Results

1. Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection

3. Impact of Air Pollution and MUC5B Genotype on Survival in Idiopathic Pulmonary Fibrosis

4. Low income and outcome in idiopathic pulmonary fibrosis: An association to uncover

7. Sarcoidosis and emergency hospitalization : causes and prognosis

8. Impact of familial character and/or the existence of a mutation in telomere-related genes in patients with pleuroparenchymal fibroelastosis

10. Pilot experience of multidisciplinary team discussion dedicated to inherited pulmonary fibrosis

11. Evaluation of Pulmonary Sarcoidosis

12. List of Contributors

13. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

18. Low income and outcome in idiopathic pulmonary fibrosis: An association to uncover

22. An expert statment on clinical considerations before treating NTM lung infection

23. Functional assessment and phenotypic heterogeneity of SFTPA1 and SFTPA2 mutations in interstitial lung diseases and lung cancer

26. Functional assessment of newly identified SFTPA1 and SFTPA2 mutations in patients with idiopathic interstitial pneumonia (IIP) and lung cancer28th International Congress of the European-Respiratory-Society (ERS)

28. Regulator of telomere length 1 (RTEL1) mutations are associated with heterogeneous pulmonary and extra-pulmonary phenotypes

29. Adding Azathioprine to Remission-Induction Glucocorticoids for Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss), Microscopic Polyangiitis, or Polyarteritis Nodosa Without Poor Prognosis Factors

30. Sarcoidosis

31. Efficacy and Tolerance of Anti–Tumor Necrosis Factor α Agents in Cutaneous Sarcoidosis

32. The N-Terminal Domain of cGAS Determines Preferential Association with Centromeric DNA and Innate Immune Activation in the Nucleus

33. Contribution of mutations in genes of the surfactant system to idiopathic interstitial pneumonia (IIP)

34. Multidisciplinary team dedicated to suspected heritable pulmonary fibrosis

35. Functional assessment of newly identified SFTPA1 and SFTPA2 mutations in patients with idiopathic interstitial pneumonia (IIP) and lung cancer

36. Efficacy and safety of tumor necrosis factor antagonists in refractory sarcoidosis: A multicenter study of 132 patients

37. SFTPA mutations in interstitial lung disease (ILD) and lung cancer

38. A genetic landscape of familial predisposition to sarcoidosis identified by whole exome sequencing

39. Efficacy and Tolerance of Anti–Tumor Necrosis Factor α Agents in Cutaneous Sarcoidosis

40. Chronic pulmonary aspergillosis complicating sarcoidosis

42. The Lung in Dysregulated States of Humoral Immunity

43. Treatment of neurosarcoidosis

44. Management of sarcoidosis in clinical practice

46. Familial vs. sporadic sarcoidosis: BTNL2 polymorphisms, clinical presentations, and outcomes in a French cohort.

47. Progressive multifocal leukoencephalopathy in patients with sarcoidosis

48. Correction: Transcriptional Blood Signatures Distinguish Pulmonary Tuberculosis, Pulmonary Sarcoidosis, Pneumonias and Lung Cancers

49. Transcriptional Blood Signatures Distinguish Pulmonary Tuberculosis, Pulmonary Sarcoidosis, Pneumonias and Lung Cancers

Catalog

Books, media, physical & digital resources